“Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S19, https://doi.org/10.25251/skin.2.supp.19.